Skip to main content
. 2018 Oct 24;22(3):291–308. doi: 10.1007/s40477-018-0332-3

Table 6.

Diagnostic performance of CDHR-NUS + 99mTc-MIBI PS for the whole series

CDHR-NUS +99mTc-MIBI PS SGD + MGD (136 patients) CI 95%
Sensibility 91% 86–95
Specificity 99% 98–100
PPV 97% 95–100
NPV 99% 97–100
LR+ 88.8 33.4–235.7
LR− 0.09 0.06–0.15